NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.

Author(s): Sorber L, Zwaenepoel K, Jacobs J, De Winne K, Goethals S, Reclusa P, Van Casteren K, Augustus E, Lardon F, Roeyen G, Peeters M, Van Meerbeeck J, Rolfo C, Pauwels P

Publication: Cancers (Basel), 2019, Vol. 11, Page

PubMed ID: 30935089 PubMed Review Paper? No

Purpose of Paper

This paper investigated the effects of tube type and centrifugation protocol on the yield of cell-free DNA (cfDNA) and cell-free RNA (cfRNA), genomic DNA contamination, and detection of KRAS-mutated circulating tumor(ct) DNA and RNA.

Conclusion of Paper

Plasma isolated by centrifugation for 10 min at 400 x g had significantly more cfDNA but also a higher percentage of long (>400 bp) fragments, indicating genomic contamination than that obtained by two step centrifugation protocols. For all centrifugation protocols, the percentage of long fragments was higher in EDTA plasma than Streck plasma. In general, KRAS ctDNA concentration and allele frequency was unaffected by centrifugation protocol with the exception of one patient in which plasma obtained by centrifugation at 400 x g was considered to be KRAS-wildtype and plasma generated by the other protocols was KRAS-mutated.

In EDTA tubes, plasma obtained by centrifugation at 400 x g (platelet-rich plasma) had significantly higher levels of cfRNA than plasma generated by other methods; however, this was due to the higher concentration of platelets which had the highest cfRNA levels. cfRNA levels were very low in plasma from Streck tubes, regardless of centrifugation protocol, precluding analysis of centrifugation protocol effects. KRAS-mutated ctRNA was only detected in platelets from EDTA blood and was not detected in any of the specimens from Streck tubes.

 

Studies

  1. Study Purpose

    This study investigated the effects of tube type and centrifugation protocol on the yield of cfDNA and cfRNA, genomic DNA contamination, and detection of KRAS-mutated ctDNA and ctRNA. Blood from 15 patients with KRAS-mutated advanced cancer and 18 healthy patients were collected into EDTA and Streck BCT tubes. Plasma was isolated from blood in EDTA tubes within 2 h of collection and from blood in Streck tubes after 24 h at room temperature. Plasma was obtained by: 1) centrifugation for 10 min at 400 x g; 2) centrifugation for 10 min at 400 x g, storage of the supernatant at -80˚C and recentrifugation for 1 min at maximum speed; 3) centrifugation for 20 min at 120 x g, centrifugation for 20 min at 360 x g (to separate plasma from platelets), platelet pellet washed in PBS and centrifuged at 360 g for 5 min; 4) centrifugation for 10 min at 1600 x g followed by centrifugation of the supernatant at 6000 x g for 10 min (Streck tubes only); or 5) centrifugation for 10 min at 1900 x g followed by centrifugation at 16000 x g. For centrifugation protocol 5, the effect of storing blood on ice and centrifugation at 4˚C was compared with room temperature storage and centrifugation of EDTA tubes. The effects of centrifugation speed on ctDNA fraction was investigated using blood from 8 cancer patients collected in EDTA (4 patients) and Streck tubes (4 patients). All plasma specimens were stored at -80˚C until cfDNA and cfRNA extraction. cfDNA was isolated using the Maxwell RSC ccfDNA large volume plasma kit. cfDNA concentration and KRAS mutational status determined using the ddPCR KRAS Screening Multiplex Kit and cfDNA concentration was also determined by real-time PCR amplification of an 82 bp fragment of Long Interspersed Nuclear Elements (LINE-1). The percentage of long DNA was determined by amplification of unspecified 425 and 82 bp amplicons. cfRNA was isolated using the miRNeasy Serum/Plasma Kit and reverse transcribed using the miScript II RT Kit. cfRNA yield and KRAS status were determined using the ddPCR KRAS Screening Multiplex Kit.

    Summary of Findings:

    Significantly more total cfDNA was obtained in plasma isolated by centrifugation for 10 min at 400 x g than in plasma obtained by the other protocols (P≤0.001, all for EDTA and P≤0.002, all for Streck) as determined by ddPCR, but there were no significant differences between the other plasma specimens.  Similarly, the quantification cycle (Cq) value for real-time PCR amplification of LINE-1 was lower in EDTA plasma obtained by centrifugation for 10 min at 400 x g than that obtained using any other method (P≤0.004) or Streck plasma obtained by centrifugation at 400 x g followed by at max speed for 1 min (P=0.043) or by centrifugation at 120 x g for 20 min, followed by 360 x g for 20 min (P=0.013). However, plasma obtained by centrifugation at 400 x g had a higher percentage of long (>400 bp) fragments, indicating more genomic contamination than other plasma specimens (P<0.0001, all for EDTA and P<0.024, all for Streck). When plasma centrifuged at 400 x g for 10 min was subsequently centrifuged for 1 min at maximum speed, the percentage of long fragments was still higher than in plasma obtained by centrifugation for 20 min at 120 x g followed by 20 min at 360 x g (P=0.003 for EDTA, and NS for Streck), centrifugation at 1600 x g for 10 min followed by 6000 x g for 10 min (not performed for EDTA, P=0.035 for Streck) and centrifugation at 1900 x g for 10 min followed by 16000 x g for 10 min (P=0.00011 for EDTA, regardless of refrigeration and P=0.031 for Streck). For all centrifugation protocols, the percentage of long fragments was higher in EDTA plasma than Streck plasma (P=0.001-0.011). KRAS ctDNA concentration and allele frequency was unaffected by centrifugation protocol with the exception of one patient in which plasma obtained by centrifugation at 400 x g was considered to be KRAS-wildtype and plasma generated by the other protocols was KRAS-mutated. Importantly, the KRAS-mutated ctDNA was not detected in the pellet except in the case with a very high mutated KRAS allele frequency (20.6-51.9%).

    For EDTA tubes, plasma obtained by centrifugation at 400 x g (platelet-rich plasma) had significantly higher levels of cfRNA than plasma generated by other methods; however, this was due to the higher concentration of platelets which had the highest cfRNA levels. As expected, centrifugation at 1900 x g for 10 min followed by 16000 x g for 10 min resulted in the lowest levels of cfRNA. cfRNA levels were very low in plasma from Streck tubes, regardless of centrifugation protocol, precluding analysis of centrifugation protocol effects. KRAS-mutated ctRNA was only detected in platelets from EDTA blood and was not detected in specimens from Streck tubes.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Streck/BCT
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    • Neoplastic - Not specified
    • Normal
    Platform:
    AnalyteTechnology Platform
    DNA Digital PCR
    DNA Real-time qPCR
    RNA Digital PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution EDTA tube
    Streck tube
    Biospecimen Aliquots and Components Centrifugation Multiple durations compared
    Multiple speeds compared
    Multiple temperatures compared
    Different number of centrifugation steps compared
    Digital PCR Specific Targeted nucleic acid KRAS

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...